Greyson intends to enter the royalty division of business and effectively license Trilexon to clients in the drug, cosmetic and toiletry industries, upon which Greyson will retain a percentage of sales from products utilizing the Trilexon delivery system.
Harvey Tauman, president and CEO of Greyson, said: “We highly anticipate the introduction of Trilexon as a new delivery method to improve effectiveness of virtually every topical application on a worldwide level.”